We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Adalimumab
Australian Public Assessment Report
Device/Product Name
Abrilada
Active ingredients
Adalimumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-01818-1-3
Submission Type
New biosimilar medicine
Decision
Approved